[English] 日本語
Yorodumi- EMDB-21408: Mycobacterium tuberculosis RNAP S456L mutant transcription initia... -
+
Open data
-
Basic information
| Entry | Database: EMDB / ID: EMD-21408 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Mycobacterium tuberculosis RNAP S456L mutant transcription initiation intermediate structure with Sorangicin | |||||||||
 Map data | Mycobacterium tuberculosis RNAP S456L mutant transcription initiation intermediate structure with Sorangicin | |||||||||
 Sample | 
  | |||||||||
 Keywords | initiation / transcription bubble / antibiotic / sorangicin / open promoter complex / TRANSCRIPTION / TRANSFERASE-DNA-ANTIBIOTIC complex | |||||||||
| Function / homology |  Function and homology informationresponse to water / bacterial-type RNA polymerase holo enzyme binding / Antimicrobial action and antimicrobial resistance in Mtb / sigma factor activity / rRNA transcription / bacterial-type RNA polymerase core enzyme binding / cytosolic DNA-directed RNA polymerase complex / DNA-directed RNA polymerase complex / peptidoglycan-based cell wall / DNA-templated transcription initiation ...response to water / bacterial-type RNA polymerase holo enzyme binding / Antimicrobial action and antimicrobial resistance in Mtb / sigma factor activity / rRNA transcription / bacterial-type RNA polymerase core enzyme binding / cytosolic DNA-directed RNA polymerase complex / DNA-directed RNA polymerase complex / peptidoglycan-based cell wall / DNA-templated transcription initiation / ribonucleoside binding / DNA-directed RNA polymerase / DNA-directed RNA polymerase activity / nucleic acid binding / protein dimerization activity / response to antibiotic / DNA-templated transcription / positive regulation of DNA-templated transcription / magnesium ion binding / DNA binding / zinc ion binding / plasma membrane / cytoplasm / cytosol Similarity search - Function  | |||||||||
| Biological species | ![]()  | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.72 Å | |||||||||
 Authors | Lilic M / Boyaci H | |||||||||
| Funding support |   United States, 1 items 
  | |||||||||
 Citation |  Journal: Proc Natl Acad Sci U S A / Year: 2020Title: The antibiotic sorangicin A inhibits promoter DNA unwinding in a rifampicin-resistant RNA polymerase. Authors: Mirjana Lilic / James Chen / Hande Boyaci / Nathaniel Braffman / Elizabeth A Hubin / Jennifer Herrmann / Rolf Müller / Rachel Mooney / Robert Landick / Seth A Darst / Elizabeth A Campbell /   ![]() Abstract: Rifampicin (Rif) is a first-line therapeutic used to treat the infectious disease tuberculosis (TB), which is caused by the pathogen (). The emergence of Rif-resistant (Rif) presents a need for new ...Rifampicin (Rif) is a first-line therapeutic used to treat the infectious disease tuberculosis (TB), which is caused by the pathogen (). The emergence of Rif-resistant (Rif) presents a need for new antibiotics. Rif targets the enzyme RNA polymerase (RNAP). Sorangicin A (Sor) is an unrelated inhibitor that binds in the Rif-binding pocket of RNAP. Sor inhibits a subset of Rif RNAPs, including the most prevalent clinical Rif RNAP substitution found in infected patients (S456>L of the β subunit). Here, we present structural and biochemical data demonstrating that Sor inhibits the wild-type RNAP by a similar mechanism as Rif: by preventing the translocation of very short RNAs. By contrast, Sor inhibits the Rif S456L enzyme at an earlier step, preventing the transition of a partially unwound promoter DNA intermediate to the fully opened DNA and blocking the template-strand DNA from reaching the active site in the RNAP catalytic center. By defining template-strand blocking as a mechanism for inhibition, we provide a mechanistic drug target in RNAP. Our finding that Sor inhibits the wild-type and mutant RNAPs through different mechanisms prompts future considerations for designing antibiotics against resistant targets. Also, we show that Sor has a better pharmacokinetic profile than Rif, making it a suitable starting molecule to design drugs to be used for the treatment of TB patients with comorbidities who require multiple medications.  | |||||||||
| History | 
  | 
-
Structure visualization
| Movie | 
 
 
  Movie viewer | 
|---|---|
| Structure viewer | EM map:  SurfView Molmil Jmol/JSmol | 
| Supplemental images | 
-
Downloads & links
-EMDB archive
| Map data |  emd_21408.map.gz | 59.5 MB |  EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) |  emd-21408-v30.xml emd-21408.xml | 27.4 KB 27.4 KB  | Display Display  |  EMDB header | 
| Images |  emd_21408.png | 154.1 KB | ||
| Filedesc metadata |  emd-21408.cif.gz | 9.4 KB | ||
| Archive directory |  http://ftp.pdbj.org/pub/emdb/structures/EMD-21408 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-21408 | HTTPS FTP  | 
-Validation report
| Summary document |  emd_21408_validation.pdf.gz | 522.7 KB | Display |  EMDB validaton report | 
|---|---|---|---|---|
| Full document |  emd_21408_full_validation.pdf.gz | 522.1 KB | Display | |
| Data in XML |  emd_21408_validation.xml.gz | 6.4 KB | Display | |
| Data in CIF |  emd_21408_validation.cif.gz | 7.3 KB | Display | |
| Arichive directory |  https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-21408 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-21408 | HTTPS FTP  | 
-Related structure data
| Related structure data | ![]() 6vvzMC ![]() 6vvsC ![]() 6vvtC ![]() 6vvvC ![]() 6vvxC ![]() 6vvyC ![]() 6vw0C C: citing same article ( M: atomic model generated by this map  | 
|---|---|
| Similar structure data | 
-
Links
| EMDB pages |  EMDB (EBI/PDBe) /  EMDataResource | 
|---|---|
| Related items in Molecule of the Month | 
-
Map
| File |  Download / File: emd_21408.map.gz / Format: CCP4 / Size: 64 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Mycobacterium tuberculosis RNAP S456L mutant transcription initiation intermediate structure with Sorangicin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
 
 Images are generated by Spider.  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.3 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Density | 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Details | EMDB XML: 
 CCP4 map header: 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Supplemental data
-
Sample components
+Entire : Mycobacterium tuberculosis RNAP S456L mutant promoter melting int...
+Supramolecule #1: Mycobacterium tuberculosis RNAP S456L mutant promoter melting int...
+Macromolecule #1: DNA-directed RNA polymerase subunit alpha
+Macromolecule #2: DNA-directed RNA polymerase subunit beta
+Macromolecule #3: DNA-directed RNA polymerase subunit beta'
+Macromolecule #4: DNA-directed RNA polymerase subunit omega
+Macromolecule #5: RNA polymerase sigma factor SigA
+Macromolecule #6: RNA polymerase-binding protein RbpA
+Macromolecule #7: RNA polymerase-binding transcription factor CarD
+Macromolecule #8: DNA (62-MER)
+Macromolecule #9: DNA (65-MER)
+Macromolecule #10: SORANGICIN A
+Macromolecule #11: ZINC ION
+Macromolecule #12: MAGNESIUM ION
-Experimental details
-Structure determination
| Method | cryo EM | 
|---|---|
 Processing | single particle reconstruction | 
| Aggregation state | particle | 
-
Sample preparation
| Buffer | pH: 8 | 
|---|---|
| Grid | Details: unspecified | 
| Vitrification | Cryogen name: ETHANE | 
-
Electron microscopy
| Microscope | FEI TITAN KRIOS | 
|---|---|
| Image recording | Film or detector model: GATAN K2 SUMMIT (4k x 4k) / Average electron dose: 71.0 e/Å2 | 
| Electron beam | Acceleration voltage: 300 kV / Electron source:  FIELD EMISSION GUN | 
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD | 
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company  | 
Movie
Controller
About Yorodumi


Keywords
Authors
United States, 1 items 
Citation
UCSF Chimera






















Z (Sec.)
Y (Row.)
X (Col.)






















Processing
